Who are Lumonus's investors?

Lumonus's investors include Oncology Ventures, Alpha Partners.

How much funding has Lumonus raised?

Lumonus has disclosed $506K raised across 1 round.

Where is Lumonus headquartered?

Lumonus is headquartered in North Sydney.

Lumonus

North Sydney · Founded 2023 · Incorporated in Australia · 2 known investors

Find your way into Lumonus

Paths you didn't know you had: your email and LinkedIn already hold routes to the Lumonus team. We find them
2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Lumonus builds an AI-powered oncology intelligence layer that acts as a workflow assistant for radiation oncology teams, integrating with major EMR, OIS, and TPS systems. Its products cover learning, automation, and knowledge management to speed up processes such as contouring and treatment planning while reducing errors.

AI & Machine Learning Digital Health Healthtech

Founders & leadership

Sarah ButlerNamed on SEC filing

Merrick HowesNamed on SEC filing

Rebecca EdwardsNamed on SEC filing

Nicholas TodhunterNamed on SEC filing

Keith HansenNamed on SEC filing

Wally CurranNamed on SEC filing

David JonesNamed on SEC filing

Investors · 2

Oncology Ventureslisted by Oncology VenturesNew Yorkvia Ben Freeberg · inferred

How we know: Oncology Ventures's portfolio page · Not right? Tell us

Alpha PartnersreportedNew York · $3M – $10M

How we know: a partner's Signal profile · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$506K disclosed across 1 round · 2025

▶$506KraisedMar 2025 · 1 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Sarah ButlerDirector
Merrick HowesExecutive Officer, Director
Rebecca EdwardsExecutive Officer
Nicholas TodhunterDirector
Keith HansenExecutive Officer, Director
Wally CurranDirector
David JonesDirector

Offering amount: $506K
Amount sold: $506K
First sale: Mar 2025
Incorporated: Other, Australia, 2023
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Luminus DevicesLuminus develops LED technology and light emitting products for diverse applications including architectural lighting, horticulture, automotive displays, and industrial systems. The company focuses on delivering superior color quality, thermal performance, and specialized light characteristics to replace conventional lighting technologies.

Luminous Robotics, Inc.Luminous Robotics develops robotics technology aimed at supporting critical infrastructure at scale.

Companies working in the same space as Lumonus.

Frequently asked questions

What does Lumonus do?: Lumonus builds an AI-powered oncology intelligence layer that acts as a workflow assistant for radiation oncology teams, integrating with major EMR, OIS, and TPS systems. Its products cover learning, automation, and knowledge management to speed up processes such as contouring and treatment planning while reducing errors.
Who are Lumonus's investors?: Lumonus's investors include Oncology Ventures, Alpha Partners.
How much funding has Lumonus raised?: Lumonus has disclosed $506K raised across 1 round.
Where is Lumonus headquartered?: Lumonus is headquartered in North Sydney.